What is Cullinan Therapeutics, Inc.'s market cap?

Cullinan Therapeutics, Inc. (CGEM) has a market capitalization of $1.12 B as of 2026-07-09, ranking #2570 among US-listed companies.

Is Cullinan Therapeutics, Inc. profitable?

In its latest fiscal year Cullinan Therapeutics, Inc. reported a net loss of $219.88M.

← All companies

Cullinan Therapeutics, Inc.

CGEM - Company ID 0001789972

Market cap$1.12 B

Rank#2570

Filings435

Cullinan Therapeutics, Inc. trades as CGEM and has a market capitalization of $1.12 B, making it the #2570 largest US-listed company by market value. This page tracks Cullinan Therapeutics, Inc. through 435 SEC filings, with financial statements and metrics updated as new reports are filed.

Research snapshot

CGEM stock, financials, and filing history

Updated

2026-07-09

Market cap$1.12 B Rank#2570 Derived price$18.30 P/E-Revenue growth-100.0%Filings435

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Filing	Type	Filed
Major company event	8-K	2026-05-18
SCHEDULE 13G/A	-	2026-05-15
Quarterly report	10-Q	2026-05-07
Major company event	8-K	2026-05-07
Insider trade	4	2026-05-06
Insider sale notice	144	2026-05-05
S-3ASR	-	2026-04-28
Proxy materials	DEFA14A	2026-04-28

Cullinan Therapeutics, Inc.

CGEM stock, financials, and filing history

Where to go from here

Key metrics

Financial performance

Key statistics

Latest filings

Similar companies

Frequently asked questions

What is Cullinan Therapeutics, Inc.'s market cap?

Is Cullinan Therapeutics, Inc. profitable?